Evan Feinberg

Founder And CEO at Genesis Therapeutics

Attleboro, Massachusetts, United States
email-iconphone-icongithub-logolinkedin-logotwitter-logostackoverflow-logofacebook-logo
Join Prog.AI to see contacts
email-iconphone-icongithub-logolinkedin-logotwitter-logostackoverflow-logofacebook-logo
Join Prog.AI to see contacts

Summary

🤩
Rockstar
🎓
Top School
Evan Feinberg is a founder and CEO with 11 years of experience building AI-first drug discovery platforms, leading Genesis Therapeutics from a Stanford PhD thesis to a venture-backed full-stack biotech. He combines deep technical expertise in graph convolutional neural networks and molecular property prediction (developed under Vijay Pande at Stanford) with hands-on industry experience as a deep learning consultant for Merck and contributions to the influential DeepChem open-source project. Trained in applied physics at Yale and computational biophysics at Schrödinger, he bridges rigorous physical science intuition with practical ML engineering to accelerate molecule design. Notably, his work spans both research-grade model innovation and production-oriented data and featurization improvements that make advanced algorithms usable in real drug programs.
code11 years of coding experience
bookBachelor of Science - BS, Bachelor of Science - BS at Yale University
bookDoctor of Philosophy - PhD, Doctor of Philosophy - PhD at Stanford University
github-logo-circle

Github Skills (9)

pandas10
machine-learning10
drug-discovery10
deep-learning10
python10
data-science10
data-processing10
pytorch9
biology8

Programming languages (3)

C++Jupyter NotebookPython

Github contributions (5)

github-logo-circle
deepchem/deepchem

Oct 2015 - Jul 2017

Democratizing Deep-Learning for Drug Discovery, Quantum Chemistry, Materials Science and Biology
Role in this project:
userData Scientist
Contributions:63 commits, 10 PRs, 2 pushes in 1 year 8 months
Contributions summary:Evan contributed to data processing and model development within the deepchem repository, focusing on the domain of drug discovery, quantum chemistry, and biology. Their commits addressed data-processing bugs, compatibility with 3D grid features, and improvements to featurization functionality. They also appear to be working on data munging efficiency and building functionality related to the use of machine learning for tasks such as the use of tox21.
chemistrysciencedrug-discoverydeep-learningbiology
pandegroup/conformation

May 2015 - Jan 2018

Contributions:1 release, 2 PRs, 69 pushes in 2 years 9 months
pythonmolecular-dynamicsmachine-learningmolecularpower
Find and Hire Top DevelopersWe’ve analyzed the programming source code of over 60 million software developers on GitHub and scored them by 50,000 skills. Sign-up on Prog,AI to search for software developers.
Request Free Trial
Evan Feinberg - Founder And CEO at Genesis Therapeutics